Shiqiao Ye

1.1k total citations
44 papers, 885 citations indexed

About

Shiqiao Ye is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Shiqiao Ye has authored 44 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Shiqiao Ye's work include Congenital heart defects research (11 papers), Bone Metabolism and Diseases (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Shiqiao Ye is often cited by papers focused on Congenital heart defects research (11 papers), Bone Metabolism and Diseases (8 papers) and Multiple Myeloma Research and Treatments (7 papers). Shiqiao Ye collaborates with scholars based in United States, China and Japan. Shiqiao Ye's co-authors include Haibo Zhao, Toshifumi Fujiwara, Jian Zhou, Stavros C. Manolagas, Mingtao Zhao, Vidu Garg, Juan Su, Xiaolin Li, Yiying Wang and Stavros C. Manolagas and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

Shiqiao Ye

42 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiqiao Ye United States 17 615 197 134 132 114 44 885
Riccardo Chiusaroli United States 17 520 0.8× 244 1.2× 41 0.3× 152 1.2× 64 0.6× 22 898
Pinglin Lai China 16 530 0.9× 148 0.8× 68 0.5× 259 2.0× 25 0.2× 31 899
Karl Köchert Germany 15 504 0.8× 368 1.9× 96 0.7× 222 1.7× 61 0.5× 26 1.6k
Heather Fairfield United States 17 412 0.7× 326 1.7× 92 0.7× 137 1.0× 327 2.9× 44 1.0k
Abbas Jafari Denmark 17 431 0.7× 236 1.2× 45 0.3× 145 1.1× 63 0.6× 35 823
Bo Yan China 14 401 0.7× 139 0.7× 92 0.7× 106 0.8× 26 0.2× 20 831
Ming Su United States 12 377 0.6× 96 0.5× 86 0.6× 162 1.2× 34 0.3× 24 884
Emel Esen United States 9 662 1.1× 206 1.0× 113 0.8× 213 1.6× 16 0.1× 10 965
Amy Y. Sato United States 13 560 0.9× 312 1.6× 49 0.4× 79 0.6× 37 0.3× 21 918
Juan A. Ardura Spain 19 687 1.1× 287 1.5× 51 0.4× 55 0.4× 20 0.2× 35 1.1k

Countries citing papers authored by Shiqiao Ye

Since Specialization
Citations

This map shows the geographic impact of Shiqiao Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiqiao Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiqiao Ye more than expected).

Fields of papers citing papers by Shiqiao Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiqiao Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiqiao Ye. The network helps show where Shiqiao Ye may publish in the future.

Co-authorship network of co-authors of Shiqiao Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Shiqiao Ye. A scholar is included among the top collaborators of Shiqiao Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiqiao Ye. Shiqiao Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yang, Cankun Wang, Shiqiao Ye, et al.. (2024). Abnormal Progenitor Cell Differentiation and Cardiomyocyte Proliferation in Hypoplastic Right Heart Syndrome. Circulation. 149(11). 888–891. 3 indexed citations
2.
Cunningham, David, Shiqiao Ye, Matthew Alonzo, et al.. (2023). Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene. Stem Cell Research. 71. 103177–103177. 1 indexed citations
3.
Cunningham, David, Shiqiao Ye, Matthew Alonzo, et al.. (2023). Characterization of an induced pluripotent stem cell line NCHi011-A from a 23-year-old female with Alagille Syndrome harboring a heterozygous JAG1 pathogenic variant. Stem Cell Research. 72. 103213–103213. 1 indexed citations
4.
Ye, Shiqiao, Cankun Wang, Zhaohui Xu, et al.. (2022). Impaired Human Cardiac Cell Development due to NOTCH1 Deficiency. Circulation Research. 132(2). 187–204. 31 indexed citations
5.
Alonzo, Matthew, Shiqiao Ye, Hui Lin, et al.. (2022). Characterization of an iPSC line NCHi006-A from a patient with hypoplastic left heart syndrome (HLHS). Stem Cell Research. 64. 102892–102892. 1 indexed citations
6.
7.
Ye, Shiqiao, et al.. (2021). Generation of Cardiomyocytes and Endothelial Cells from Human iPSCs by Chemical Modulation of Wnt Signaling. Methods in molecular biology. 2549. 335–344. 5 indexed citations
8.
Zhao, Mingtao, Shiqiao Ye, Juan Su, & Vidu Garg. (2020). Cardiomyocyte Proliferation and Maturation: Two Sides of the Same Coin for Heart Regeneration. Frontiers in Cell and Developmental Biology. 8. 594226–594226. 59 indexed citations
9.
Qiang, Ya‐Wei, Shiqiao Ye, Yu Chen, et al.. (2017). MAFA Expression Promotes Proliferation of Myeloma Cells and Its Protein Stability Is Regulated By Proteasome Inhibitors. Blood. 130. 4394–4394.
10.
Ye, Shiqiao, Toshifumi Fujiwara, Jian Zhou, Kottayil I. Varughese, & Haibo Zhao. (2016). LIS1 Regulates Osteoclastogenesis through Modulation of M-SCF and RANKL Signaling Pathways and CDC42. International Journal of Biological Sciences. 12(12). 1488–1499. 11 indexed citations
11.
Fujiwara, Toshifumi, Jian Zhou, Shiqiao Ye, & Haibo Zhao. (2016). RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival. Cell Death and Disease. 7(7). e2300–e2300. 20 indexed citations
12.
Qiang, Ya‐Wei, Shiqiao Ye, Ricky D. Edmondson, et al.. (2015). Identification of Biomarkers Associated with MAF-Mediated Resistance to Proteasome Inhibitors in t(14;16) Multiple Myeloma. Blood. 126(23). 3020–3020. 1 indexed citations
13.
Zhou, Jian, Toshifumi Fujiwara, Shiqiao Ye, Xiaolin Li, & Haibo Zhao. (2014). Downregulation of Notch Modulators, Tetraspanin 5 and 10, Inhibits Osteoclastogenesis in Vitro. Calcified Tissue International. 95(3). 209–217. 38 indexed citations
14.
Ye, Shiqiao, Liduan Zheng, Qing‐Rong Liu, et al.. (2014). Selective 14-3-3γ induction quenches p-β-catenin Ser37/Bax-enhanced cell death in cerebral cortical neurons during ischemia. Cell Death and Disease. 5(4). e1184–e1184. 25 indexed citations
15.
Hu, Bo, Yu Chen, Saad Z. Usmani, et al.. (2013). Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma. PLoS ONE. 8(9). e74191–e74191. 36 indexed citations
17.
Ye, Shiqiao, Tristan W. Fowler, Nathan J. Pavlos, et al.. (2011). LIS1 Regulates Osteoclast Formation and Function through Its Interactions with Dynein/Dynactin and Plekhm1. PLoS ONE. 6(11). e27285–e27285. 42 indexed citations
18.
Ye, Shiqiao, et al.. (2009). Silencing neuroglobin enhances neuronal vulnerability to oxidative injury by down-regulating 14-3-3γ. Acta Pharmacologica Sinica. 30(7). 913–918. 37 indexed citations
19.
Wang, Xianghong, et al.. (2005). Role of histamine in airway remodeling of asthmatic guinea pig.. PubMed. 57(6). 725–30. 2 indexed citations
20.
Jin, Si, Shiqiao Ye, Hong Ye, et al.. (2005). A simplified probe preparation for ELISA-based NF-κB activity assay. Journal of Biochemical and Biophysical Methods. 65(1). 20–29. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026